cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.6084/m9.figshare.19208373
title: exp2_raw_anonymized

description: raw, anonymized data of experiment 2<br>
DOI: 10.6084/m9.figshare.19208373.v1
title: exp2_raw_anonymized

description: raw, anonymized data of experiment 2<br>
DOI: 10.25345/c5fb4wm9p
title: MassIVE Reanalysis RMSV000000354.4314 - CCMS MassIVE Knowledge Base (MassIVE-KB) MS-GF+ reanalysis of Bioplex AP-MS Dataset for Library Construction, NAPRT1 [launched by fce971e5ede541cca3fc5307a73294d8]
title: Center for Computational Mass Spectrometry (CCMS) systematic reanalysis of public proteomics mass spectrometry (MS) datasets provides a public, large-scale and comparable set of dataset reanalyses results including detailed provenance records. To further facilitate the broad reusability of public proteomics MS data, these reanalyses were also used to build the MassIVE Knowledge Base (MassIVE-KB) spectral library, a community-wide resource derived from hundreds of millions of identified spectra from tens of terabytes of mass spectrometry data.
DOI: 10.6084/m9.figshare.19208355.v1
title: exp1_raw_anonymized

description: Raw, anonymized data from an auditory perceptual decision-making task of study investigating choice history biases in relation to psychosis proneness. <br>
DOI: 10.6084/m9.figshare.19208355
title: exp1_raw_anonymized

description: Raw, anonymized data from an auditory perceptual decision-making task of study investigating choice history biases in relation to psychosis proneness. <br>
DOI: 10.25345/c55t3g12p
title: MassIVE Reanalysis RMSV000000354.4315 - CCMS MassIVE Knowledge Base (MassIVE-KB) MS-GF+ reanalysis of Bioplex AP-MS Dataset for Library Construction, C6orf26 [launched by fce971e5ede541cca3fc5307a73294d8]
title: Center for Computational Mass Spectrometry (CCMS) systematic reanalysis of public proteomics mass spectrometry (MS) datasets provides a public, large-scale and comparable set of dataset reanalyses results including detailed provenance records. To further facilitate the broad reusability of public proteomics MS data, these reanalyses were also used to build the MassIVE Knowledge Base (MassIVE-KB) spectral library, a community-wide resource derived from hundreds of millions of identified spectra from tens of terabytes of mass spectrometry data.
DOI: 10.25345/c59k45t6d
title: MassIVE Reanalysis RMSV000000354.4317 - CCMS MassIVE Knowledge Base (MassIVE-KB) MS-GF+ reanalysis of Bioplex AP-MS Dataset for Library Construction, CLEC14A [launched by fce971e5ede541cca3fc5307a73294d8]
title: Center for Computational Mass Spectrometry (CCMS) systematic reanalysis of public proteomics mass spectrometry (MS) datasets provides a public, large-scale and comparable set of dataset reanalyses results including detailed provenance records. To further facilitate the broad reusability of public proteomics MS data, these reanalyses were also used to build the MassIVE Knowledge Base (MassIVE-KB) spectral library, a community-wide resource derived from hundreds of millions of identified spectra from tens of terabytes of mass spectrometry data.
DOI: 10.6084/m9.figshare.19169318
title: exp2_model1_visual

description: Pre-processed data from Experiment 2 (visual perceptual decision-making on random dot kinematograms). <br><br>For coding and more information on the variables, see the note in this figshare repository. <br>
DOI: 10.6084/m9.figshare.19169318.v1
title: exp2_model1_visual

description: Pre-processed data from Experiment 2 (visual perceptual decision-making on random dot kinematograms). <br><br>For coding and more information on the variables, see the note in this figshare repository. <br>
DOI: 10.6084/m9.figshare.19169276
title: exp1_model1_auditory

description: Pre-processed data from Exp. 1 (auditory perceptual decision-making task) <br><br>For coding and more information on the variables, see the comment in this figshare repository. <br>
DOI: 10.6084/m9.figshare.19169276.v1
title: exp1_model1_auditory

description: Pre-processed data from Exp. 1 (auditory perceptual decision-making task) <br><br>For coding and more information on the variables, see the comment in this figshare repository. <br>
DOI: 10.6073/pasta/55558b15424e960b0e5011d6f2004f88
title: APT01 Daily precipitation amounts measured at multiple sites across konza prairie

description: Data set contains daily records of precipitation on 10 raingauges at 10 sites on Konza Prairie. Two sites (020A and 002C; SE) have 7-day clocks (one revolution per week), 7 have 24-hour clocks (one revolution per day), and the Headquarters raingauge generates daily data and 15 minute data. The Headquarters raingauge generates data year round. The remaining rain gauges are operated from April 1 to October 31. Precipitation amounts are recorded in mm. As of 2011, the HQ 1 (7-day clock) and HQ 2 (24-hour clock) raingauges have been discontinued and replaced with an Ott Pluvio2 rainguage that began data generation March 2010.
DOI: 10.25345/c5251fm0p
title: MassIVE Reanalysis RMSV000000354.4316 - CCMS MassIVE Knowledge Base (MassIVE-KB) MS-GF+ reanalysis of Bioplex AP-MS Dataset for Library Construction, FUS [launched by fce971e5ede541cca3fc5307a73294d8]
title: Center for Computational Mass Spectrometry (CCMS) systematic reanalysis of public proteomics mass spectrometry (MS) datasets provides a public, large-scale and comparable set of dataset reanalyses results including detailed provenance records. To further facilitate the broad reusability of public proteomics MS data, these reanalyses were also used to build the MassIVE Knowledge Base (MassIVE-KB) spectral library, a community-wide resource derived from hundreds of millions of identified spectra from tens of terabytes of mass spectrometry data.
DOI: 10.48370/ofd/38zbfm/rgycji
title: Anthaxia fulgurans.JPG

description: :unav
DOI: 10.48370/ofd/38zbfm
title: Anthaxia (s.str.) fulgurans (Schrank, 1789)), C-322

description: Coleoptera collection
DOI: 10.5281/zenodo.6223223
title: Nisaetus cirrhatus SPAdes preassembly

description: .
DOI: 10.5281/zenodo.6223222
title: Nisaetus cirrhatus SPAdes preassembly

description: .
DOI: 10.5258/soton/d1986
title: Navigating the Red Sea: A spatiotemporal approach to investigating 18th-19th century CE indigenous seafaring:

description: Dataset for University of Southampton Doctoral Thesis. "Navigating the Red Sea: A spatiotemporal approach to investigating 18th-19th century CE indigenous seafaring". Traditional Red Sea Voyages, 1750s to 1850s. This is a .kmz file created in Google Earth. This file includes story maps of 22 traditional voyages undertaken in the Red Sea between 1750-1850.
DOI: 10.5281/zenodo.6223040
title: Spizaetus melanoleucus SPAdes preassembly

description: .
DOI: 10.5281/zenodo.6223039
title: Spizaetus melanoleucus SPAdes preassembly

description: .
DOI: 10.48370/ofd/bzdc3i/go1wle
title: Anthaxia fulgurans 1.JPG

description: :unav
DOI: 10.48370/ofd/bzdc3i
title: Anthaxia (s.str.) fulgurans (Schrank, 1789)), C-323

description: Coleoptera collection
DOI: 10.25345/c5xd0qz5p
title: MassIVE Reanalysis RMSV000000354.4320 - CCMS MassIVE Knowledge Base (MassIVE-KB) MS-GF+ reanalysis of Bioplex AP-MS Dataset for Library Construction, NDUFS1 [launched by fce971e5ede541cca3fc5307a73294d8]
title: Center for Computational Mass Spectrometry (CCMS) systematic reanalysis of public proteomics mass spectrometry (MS) datasets provides a public, large-scale and comparable set of dataset reanalyses results including detailed provenance records. To further facilitate the broad reusability of public proteomics MS data, these reanalyses were also used to build the MassIVE Knowledge Base (MassIVE-KB) spectral library, a community-wide resource derived from hundreds of millions of identified spectra from tens of terabytes of mass spectrometry data.
DOI: 10.25345/c5sn0151b
title: MassIVE Reanalysis RMSV000000354.4318 - CCMS MassIVE Knowledge Base (MassIVE-KB) MS-GF+ reanalysis of Bioplex AP-MS Dataset for Library Construction, KATNA1 [launched by fce971e5ede541cca3fc5307a73294d8]
title: Center for Computational Mass Spectrometry (CCMS) systematic reanalysis of public proteomics mass spectrometry (MS) datasets provides a public, large-scale and comparable set of dataset reanalyses results including detailed provenance records. To further facilitate the broad reusability of public proteomics MS data, these reanalyses were also used to build the MassIVE Knowledge Base (MassIVE-KB) spectral library, a community-wide resource derived from hundreds of millions of identified spectra from tens of terabytes of mass spectrometry data.
DOI: 10.25345/c5nv99b71
title: MassIVE Reanalysis RMSV000000354.4319 - CCMS MassIVE Knowledge Base (MassIVE-KB) MS-GF+ reanalysis of Bioplex AP-MS Dataset for Library Construction, GPR84 [launched by fce971e5ede541cca3fc5307a73294d8]
title: Center for Computational Mass Spectrometry (CCMS) systematic reanalysis of public proteomics mass spectrometry (MS) datasets provides a public, large-scale and comparable set of dataset reanalyses results including detailed provenance records. To further facilitate the broad reusability of public proteomics MS data, these reanalyses were also used to build the MassIVE Knowledge Base (MassIVE-KB) spectral library, a community-wide resource derived from hundreds of millions of identified spectra from tens of terabytes of mass spectrometry data.
DOI: 10.6084/m9.figshare.17080730.v1
title: Definitive therapy for squamous cell carcinoma of the anus with synchronous metastases – a report from the Danish Anal Cancer Group

description: Definitive therapy for squamous cell carcinoma of the anus with synchronous metastases – a report from the Danish Anal Cancer Group
DOI: 10.6084/m9.figshare.19103221
title: Long-term satisfaction with curative treatment and follow-up in prostate cancer survivors

description: In a cross-sectional observational study to explore long-term satisfaction with treatment among men who had undergone radical prostatectomy (RP) or definitive pelvic radiotherapy (RT) for prostate cancer (PCa). After mean 7 years from therapy (range: 6–8), 431 PCa-survivors (RP: <i>n</i> = 313, RT: <i>n</i> = 118) completed a mailed questionnaire assessing persistent treatment-related adverse effects (AEs) (Expanded Prostate cancer Index Composite [EPIC-26]) and seven Quality indicators describing satisfaction with the health care service following a most often general practitioner (GP)-led follow-up plan. A logistic regression model evaluated the associations between long-term satisfaction and treatment modality, age, the seven satisfaction-related Quality indicators, and persistent AEs. The significance level was set at <i>p</i> Four of five (81%) PCa-survivors reported long-term satisfaction with their treatment. In a multivariable model, satisfaction was positively associated with sufficient information about treatment and AEs, patient-perceived sufficient cooperation between the hospital and the GP and sufficient follow-up of AEs (ref.: insufficient). Age ≥70 years (ref.: &lt;70) and a rising summary score within the EPIC-26 sexual domain additionally increased long-term satisfaction. The treatment modality itself (RP <i>versus</i> RT) did not significantly impact on satisfaction. The majority of curatively treated PCa-survivors are satisfied with their treatment more than 5 years after primary therapy. Sufficient information, improved cooperation between the hospital specialists and the responsible GP and optimized follow-up of AEs may further increase long-term satisfaction among prostatectomized and irradiated PCa-survivors.
DOI: 10.6084/m9.figshare.16799827
title: Cognitive interference processing in adult survivors of childhood acute lymphoblastic leukemia using functional magnetic resonance imaging

description: Childhood acute lymphoblastic leukemia (ALL) is associated with cognitive impairment in adulthood. Cognitive interference processing and its correlated functional magnetic resonance imaging (fMRI) activity in the brain have not yet been studied in this patient group. Twenty-six adult childhood ALL survivors (median [interquartile range {IQR}] age, 40.0 [37.0–42.3] years) were investigated at median age (IQR), 35.0 (32.0–37.0) years after treatment with intrathecal and intravenous chemotherapy as well as cranial radiotherapy (24 Gy) and compared with 26 matched controls (median [IQR] age, 37.5 [33.0–41.5] years). Cognitive interference processing was investigated in terms of behavioral performance (response times [ms] and accuracy performance [%]) and fMRI activity in the cingulo-fronto-parietal (CFP) attention network as well as other parts of the brain using the multisource interference task (MSIT). ALL survivors had longer response times and reduced accuracy performance during cognitive interference processing (median [IQR] interference effect, 371.9 [314.7–453.3] ms and 6.7 [4.2–14.7]%, respectively) comparedwith controls (303.7 [275.0–376.7] ms and 2.3 [1.6–4.3]%, respectively), but did not exhibit altered fMRI activity in the CFP attention network or elsewhere in the brain. Adult childhood ALL survivors demonstrated impaired behavioral performance but no altered fMRI activity when performing cognitive interference processing when compared with controls. The results can be used to better characterize this patient group and to optimize follow-up care and support for these individuals.
DOI: 10.6084/m9.figshare.17080730
title: Definitive therapy for squamous cell carcinoma of the anus with synchronous metastases – a report from the Danish Anal Cancer Group

description: Definitive therapy for squamous cell carcinoma of the anus with synchronous metastases – a report from the Danish Anal Cancer Group
DOI: 10.6084/m9.figshare.19103221.v1
title: Long-term satisfaction with curative treatment and follow-up in prostate cancer survivors

description: In a cross-sectional observational study to explore long-term satisfaction with treatment among men who had undergone radical prostatectomy (RP) or definitive pelvic radiotherapy (RT) for prostate cancer (PCa). After mean 7 years from therapy (range: 6–8), 431 PCa-survivors (RP: <i>n</i> = 313, RT: <i>n</i> = 118) completed a mailed questionnaire assessing persistent treatment-related adverse effects (AEs) (Expanded Prostate cancer Index Composite [EPIC-26]) and seven Quality indicators describing satisfaction with the health care service following a most often general practitioner (GP)-led follow-up plan. A logistic regression model evaluated the associations between long-term satisfaction and treatment modality, age, the seven satisfaction-related Quality indicators, and persistent AEs. The significance level was set at <i>p</i> Four of five (81%) PCa-survivors reported long-term satisfaction with their treatment. In a multivariable model, satisfaction was positively associated with sufficient information about treatment and AEs, patient-perceived sufficient cooperation between the hospital and the GP and sufficient follow-up of AEs (ref.: insufficient). Age ≥70 years (ref.: &lt;70) and a rising summary score within the EPIC-26 sexual domain additionally increased long-term satisfaction. The treatment modality itself (RP <i>versus</i> RT) did not significantly impact on satisfaction. The majority of curatively treated PCa-survivors are satisfied with their treatment more than 5 years after primary therapy. Sufficient information, improved cooperation between the hospital specialists and the responsible GP and optimized follow-up of AEs may further increase long-term satisfaction among prostatectomized and irradiated PCa-survivors.
DOI: 10.6084/m9.figshare.16799827.v1
title: Cognitive interference processing in adult survivors of childhood acute lymphoblastic leukemia using functional magnetic resonance imaging

description: Childhood acute lymphoblastic leukemia (ALL) is associated with cognitive impairment in adulthood. Cognitive interference processing and its correlated functional magnetic resonance imaging (fMRI) activity in the brain have not yet been studied in this patient group. Twenty-six adult childhood ALL survivors (median [interquartile range {IQR}] age, 40.0 [37.0–42.3] years) were investigated at median age (IQR), 35.0 (32.0–37.0) years after treatment with intrathecal and intravenous chemotherapy as well as cranial radiotherapy (24 Gy) and compared with 26 matched controls (median [IQR] age, 37.5 [33.0–41.5] years). Cognitive interference processing was investigated in terms of behavioral performance (response times [ms] and accuracy performance [%]) and fMRI activity in the cingulo-fronto-parietal (CFP) attention network as well as other parts of the brain using the multisource interference task (MSIT). ALL survivors had longer response times and reduced accuracy performance during cognitive interference processing (median [IQR] interference effect, 371.9 [314.7–453.3] ms and 6.7 [4.2–14.7]%, respectively) comparedwith controls (303.7 [275.0–376.7] ms and 2.3 [1.6–4.3]%, respectively), but did not exhibit altered fMRI activity in the CFP attention network or elsewhere in the brain. Adult childhood ALL survivors demonstrated impaired behavioral performance but no altered fMRI activity when performing cognitive interference processing when compared with controls. The results can be used to better characterize this patient group and to optimize follow-up care and support for these individuals.
DOI: 10.6084/m9.figshare.16918560
title: Socioeconomic disparities in the prevalence of comorbid chronic conditions among Canadian adults with cancer

description: To evaluate the prevalence of comorbid chronic conditions among Canadian adults with cancer and the impact of socioeconomic background on the distribution of these conditions. Canadian Community Health Survey (CCHS) 2017–2018 dataset was accessed and individuals with complete information about cancer history were reviewed. The prevalence of the following 10 chronic conditions was reviewed: asthma, chronic obstructive pulmonary disease, arthritis, hypertension, hypercholesterolemia/hyperlipidemia, heart disease, stroke, diabetes, mood disorder, and anxiety disorder. Stratification of the prevalence was done according to age, sex, and racial subgroups. Multivariable logistic regression analysis was done to evaluate the association between sociodemographic characteristics and having multiple comorbid conditions. A total of 104,362 participants were included in the current study (including 10,782 participants with a history of cancer; and 93,580 participants without a history of cancer). Among all age, sex, and race strata, participants with a history of cancer were more likely to have multiple chronic conditions (<i>p</i> History of cancer is associated with a higher probability of many comorbid conditions. This excess comorbidity burden seems to be unequally shouldered by individuals in the lower socioeconomic stratum as well as minority populations.
DOI: 10.6084/m9.figshare.17373024.v1
title: Age and prognosis in patients with pancreatic cancer: a population-based study

description: The diagnosis of pancreatic ductal adenocarcinoma (PDAC) has an enormous impact on patients, and even more so if they are of younger age. It is unclear how their treatment and outcome compare to older patients. This study compares clinicopathological characteristics and overall survival (OS) of PDAC patients aged &lt;60 years to older PDAC patients. This is a retrospective, population-based cohort study using Netherlands Cancer Registry data of patients diagnosed with PDAC (1 January 2015–31 December 2018). Kaplan–Meier curves and Cox proportional hazards models were used to assess OS. Overall, 10,298 patients were included, of whom 1551 (15%) were &lt;60 years. Patients &lt;60 years were more often male, had better performance status, less comorbidities and less stage I disease, and more often received anticancer treatment (67 <i>vs.</i> 33%, <i>p</i> vs. 14%<i>p</i> vs. 3.3 months, <i>p</i> vs. 19.4 months, <i>p</i> = 0.123), received chemotherapy alone (7.8 <i>vs.</i> 8.5 months, <i>p</i> = 0.191), or received no anticancer treatment (1.8 <i>vs.</i> 1.9 months, <i>p</i> = 0.600). Patients &lt;60 years with stage-IV disease receiving chemotherapy had a somewhat better OS (7.5 <i>vs.</i> 6.3 months, <i>p</i> = 0.026). Patients with PDAC &lt;60 years more often underwent resection despite less stage I disease and had superior OS. Stratified for treatment, however, survival was largely similar.
DOI: 10.6084/m9.figshare.16918560.v1
title: Socioeconomic disparities in the prevalence of comorbid chronic conditions among Canadian adults with cancer

description: To evaluate the prevalence of comorbid chronic conditions among Canadian adults with cancer and the impact of socioeconomic background on the distribution of these conditions. Canadian Community Health Survey (CCHS) 2017–2018 dataset was accessed and individuals with complete information about cancer history were reviewed. The prevalence of the following 10 chronic conditions was reviewed: asthma, chronic obstructive pulmonary disease, arthritis, hypertension, hypercholesterolemia/hyperlipidemia, heart disease, stroke, diabetes, mood disorder, and anxiety disorder. Stratification of the prevalence was done according to age, sex, and racial subgroups. Multivariable logistic regression analysis was done to evaluate the association between sociodemographic characteristics and having multiple comorbid conditions. A total of 104,362 participants were included in the current study (including 10,782 participants with a history of cancer; and 93,580 participants without a history of cancer). Among all age, sex, and race strata, participants with a history of cancer were more likely to have multiple chronic conditions (<i>p</i> History of cancer is associated with a higher probability of many comorbid conditions. This excess comorbidity burden seems to be unequally shouldered by individuals in the lower socioeconomic stratum as well as minority populations.
DOI: 10.25345/c5j38kj36
title: MassIVE Reanalysis RMSV000000354.4321 - CCMS MassIVE Knowledge Base (MassIVE-KB) MS-GF+ reanalysis of Bioplex AP-MS Dataset for Library Construction, ICOS [launched by fce971e5ede541cca3fc5307a73294d8]
title: Center for Computational Mass Spectrometry (CCMS) systematic reanalysis of public proteomics mass spectrometry (MS) datasets provides a public, large-scale and comparable set of dataset reanalyses results including detailed provenance records. To further facilitate the broad reusability of public proteomics MS data, these reanalyses were also used to build the MassIVE Knowledge Base (MassIVE-KB) spectral library, a community-wide resource derived from hundreds of millions of identified spectra from tens of terabytes of mass spectrometry data.
DOI: 10.25345/c5db7vr0j
title: MassIVE Reanalysis RMSV000000354.4322 - CCMS MassIVE Knowledge Base (MassIVE-KB) MS-GF+ reanalysis of Bioplex AP-MS Dataset for Library Construction, RHOT2 [launched by fce971e5ede541cca3fc5307a73294d8]
title: Center for Computational Mass Spectrometry (CCMS) systematic reanalysis of public proteomics mass spectrometry (MS) datasets provides a public, large-scale and comparable set of dataset reanalyses results including detailed provenance records. To further facilitate the broad reusability of public proteomics MS data, these reanalyses were also used to build the MassIVE Knowledge Base (MassIVE-KB) spectral library, a community-wide resource derived from hundreds of millions of identified spectra from tens of terabytes of mass spectrometry data.
DOI: 10.6084/m9.figshare.16802548
title: Ab-CoV_neut_profile.csv

description: Neutralization profile of SARS-CoV-2 related antibodies. The work will be accessible after publication.
DOI: 10.6084/m9.figshare.16802548.v2
title: Ab-CoV_neut_profile.csv

description: Neutralization profile of SARS-CoV-2 related antibodies. The work will be accessible after publication.
DOI: 10.6084/m9.figshare.16802548.v1
title: Ab-CoV_neut_profile.csv

description: Neutralization profile of SARS-CoV-2 related antibodies. The work will be accessible after publication.
DOI: 10.34740/kaggle/dsv/3216247
title: COVID Vaccination in World (updated daily)
DOI: 10.48370/ofd/d73c52/f9fcd4
title: Anthaxia bicolor.JPG

description: :unav